Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1979 1
1985 1
1987 3
1988 1
1991 1
1992 2
1993 1
1995 2
1996 1
1997 1
1998 1
1999 1
2002 3
2003 1
2004 5
2005 4
2006 4
2007 7
2008 15
2009 12
2010 8
2011 7
2012 9
2013 8
2014 12
2015 15
2016 16
2017 24
2018 26
2019 16
2020 15
2021 30
2022 50
2023 41
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

313 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for alejandro months
Search for Alejandro Montes instead (2 results)
Management of lumbar spondylolisthesis: A retrospective analysis of posterior lumbar interbody fusion versus transforaminal lumbar interbody fusion.
Encarnacion-Santos D, Nurmukhametov R, Donasov M, Volovich A, Bozkurt I, Wellington J, Espinal-Lendof M, Peralta I, Chaurasia B. Encarnacion-Santos D, et al. J Craniovertebr Junction Spine. 2024 Jan-Mar;15(1):99-104. doi: 10.4103/jcvjs.jcvjs_74_23. Epub 2024 Mar 13. J Craniovertebr Junction Spine. 2024. PMID: 38644921 Free PMC article.
METHODOLOGY: A retrospective analysis of patients who underwent interbody fusion for lumbar stenosis through PLIF and minimally invasive (MI)-TLIF was performed. The patients were followed up for 24 months and fusion rates, Visual Analog Score (VAS), and Oswestry Disabilit …
METHODOLOGY: A retrospective analysis of patients who underwent interbody fusion for lumbar stenosis through PLIF and minimally invasive (MI …
Inequality in breastfeeding and complementary feeding practices in Argentina by household income level in 2018-2019.
Zapata ME, Rovirosa A, Nessier MC, Romero Mathieu N, Gijena JR, Bonet AM. Zapata ME, et al. Arch Argent Pediatr. 2024 Apr 18:e202310221. doi: 10.5546/aap.2023-10221.eng. Online ahead of print. Arch Argent Pediatr. 2024. PMID: 38608003 Free article. English, Spanish.
Results. The analysis included 5763 children younger than 24 months old. Although 97% was ever breastfed, only 47% of infants younger than 6 months were exclusively breastfed the previous day and 48% continued with breastfeeding after 1 year old, with a higher preva …
Results. The analysis included 5763 children younger than 24 months old. Although 97% was ever breastfed, only 47% of infants younger …
Mortality, Functional Status, and Quality of Life after 5 Years of Patients Admitted to Critical Care for Spontaneous Intracerebral Hemorrhage.
Gordillo-Resina M, Aranda-Martinez C, Arias-Verdú MD, Guerrero-López F, Castillo-Lorente E, Rodríguez-Rubio D, Rivera-López R, Rosa-Garrido C, Gómez-Jiménez FJ, Lafuente-Baraza J, Aguilar-Alonso E, Arráez-Sánchez MA, Rivera-Fernández R. Gordillo-Resina M, et al. Neurocrit Care. 2024 Apr 8. doi: 10.1007/s12028-024-01960-0. Online ahead of print. Neurocrit Care. 2024. PMID: 38589693
In the Glasgow Outcome Scale, a normal or disabled self-sufficient situation was recorded in 21.5% of patients at 6 months, in 25.5% of patients after 1 year, and in 22.1% of patients after 5 years of follow-up (4.5% missing). The Barthel Index score of survivors improved …
In the Glasgow Outcome Scale, a normal or disabled self-sufficient situation was recorded in 21.5% of patients at 6 months, in 25.5% …
Circulating tumor DNA for predicting recurrence in patients with operable breast cancer: a systematic review and meta-analysis.
Nader-Marta G, Monteforte M, Agostinetto E, Cinquini M, Martins-Branco D, Langouo M, Llombart-Cusac A, Cortés J, Ignatiadis M, Torri V, Apolone G, Cappelletti V, Pruneri G, de Azambuja E, Di Cosimo S. Nader-Marta G, et al. ESMO Open. 2024 Mar;9(3):102390. doi: 10.1016/j.esmoop.2024.102390. Epub 2024 Mar 10. ESMO Open. 2024. PMID: 38460249 Free PMC article.
The mean lead time from ctDNA detection to overt recurrence was 10.81 months (range 0-58.9 months). CONCLUSIONS: ctDNA detection was associated with worse DFS and OS in patients with operable BC, particularly when detected after treatment and using primary tumor-inf …
The mean lead time from ctDNA detection to overt recurrence was 10.81 months (range 0-58.9 months). CONCLUSIONS: ctDNA detecti …
Effectiveness and safety of azathioprine for inflammatory pouch disorders: results from the RESERVO study of GETECCU.
Mesonero F, Zabana Y, Fernández-Clotet A, Leo-Carnerero E, Caballol B, Núñez-Ortiz A, García MJ, Bertoletti F, Mínguez A, Suris G, Casis B, Ferreiro-Iglesias R, Calafat M, Jiménez I, Miranda-Bautista J, Lamuela LJ, Fajardo I, Torrealba L, Nájera R, Sáiz-Chumillas RM, González I, Vicuña M, García-Morales N, Gutiérrez A, López-García A, Benítez JM, Rubín de Célix C, Tejido C, Brunet E, Hernández-Camba A, Suárez C, Rodríguez-Lago I, Piqueras M, Castaño A, Ramos L, Sobrino A, Rodríguez-Grau MC, Elosua A, Montoro M, Baltar R, Huguet JM, Hermida B, Caballero-Mateos A, Sánchez-Guillén L, Bouhmidi A, Pajares R, Baston-Rey I, López-Sanromán A, Albillos A, Barreiro-de Acosta M. Mesonero F, et al. Therap Adv Gastroenterol. 2024 Mar 4;17:17562848241234476. doi: 10.1177/17562848241234476. eCollection 2024. Therap Adv Gastroenterol. 2024. PMID: 38445247 Free PMC article.
The rate of clinical response, remission and non-response at 12 months were 52%, 30% and 18%, respectively. After a median follow-up of 23 months (interquartile range 11-55), 19 patients (30%) were in clinical remission, and 45 (66%) stopped therapy. ...
The rate of clinical response, remission and non-response at 12 months were 52%, 30% and 18%, respectively. After a median follow-up …
Disease-free survival and response to therapy of clinically node- negative Papillary Thyroid Cancer treated without central neck dissection: Retrospective study of 321 patients.
Ruiz-García C, Riesco LR, Mateos-Serrano B, Millán RB, Muñoz AJDP, Bouzas JG, Ramírez PP, Marcos PM, Catalán AL, Lecumberri B, Álvarez-Escolá C, Castro A. Ruiz-García C, et al. Acta Otorrinolaringol Esp (Engl Ed). 2024 Feb 10:S2173-5735(24)00021-8. doi: 10.1016/j.otoeng.2024.01.006. Online ahead of print. Acta Otorrinolaringol Esp (Engl Ed). 2024. PMID: 38346491
RESULTS: 321 patients were identified, mostly T1-T2 tumors (94.1%). Median follow-up was 90 months. DFS in the central compartment was excellent (96.1% at 10 year's follow-up). 19 patients had cervical recurrence, of which 15 underwent salvage surgery. ...
RESULTS: 321 patients were identified, mostly T1-T2 tumors (94.1%). Median follow-up was 90 months. DFS in the central compartment wa …
Oleosome interfacial engineering to enhance their functionality in foods.
Ghazani SM, Hargreaves J, Guldiken B, Mata A, Pensini E, Marangoni AG. Ghazani SM, et al. Curr Res Food Sci. 2024 Jan 17;8:100682. doi: 10.1016/j.crfs.2024.100682. eCollection 2024. Curr Res Food Sci. 2024. PMID: 38304001 Free PMC article.
The oleosome sample with 40% glycerol showed high storage stability at 4 C (over three months). The addition of glycerol also decreased the water activity of the oleosome suspension to 0.85, which could prevent microbial growth....
The oleosome sample with 40% glycerol showed high storage stability at 4 C (over three months). The addition of glycerol also decreas …
Lurbinectedin in patients with small cell lung cancer with chemotherapy-free interval ≥30 days and without central nervous metastases.
Peters S, Trigo J, Besse B, Moreno V, Navarro A, Eugenia Olmedo M, Paz-Ares L, Grohé C, Antonio Lopez-Vilariño J, Fernández C, Kahatt C, Alfaro V, Nieto A, Zeaiter A, Subbiah V. Peters S, et al. Lung Cancer. 2024 Feb;188:107448. doi: 10.1016/j.lungcan.2023.107448. Epub 2023 Dec 27. Lung Cancer. 2024. PMID: 38198859 Free article. Clinical Trial.
RESULTS: Lurbinectedin showed a statistically significant higher overall response rate (ORR) by investigator assessment (IA) compared to topotecan subgroup (41.0 % vs. 25.5 %; p = 0.0382); higher ORR by Independent Review Committee (IRC) (33.7 % vs. 25.5 %); longer median duratio …
RESULTS: Lurbinectedin showed a statistically significant higher overall response rate (ORR) by investigator assessment (IA) compared to top …
Influence of rheumatoid factor on serum drug levels of tumour necrosis factor inhibitors with different structures in rheumatoid arthritis.
Martínez-Feito A, Plasencia-Rodríguez C, Novella-Navarro M, Gehin JE, Hernández-Breijo B, Brenis CM, Villalba-Yllán A, Fernández E, Monjo-Henry I, Pascual-Salcedo D, Nozal P, Balsa A. Martínez-Feito A, et al. Clin Exp Rheumatol. 2024 Jan 8. doi: 10.55563/clinexprheumatol/ig40gm. Online ahead of print. Clin Exp Rheumatol. 2024. PMID: 38197184
Demographic and clinical variables, RF and ACPA levels were obtained at the baseline visit (T0), and patients were stratified based on negative, low, medium, or high levels. After 6 months (T6) serum drug levels and anti-drug antibodies (ADAb), were computed. ...ADAb was o …
Demographic and clinical variables, RF and ACPA levels were obtained at the baseline visit (T0), and patients were stratified based on negat …
The Roles of Protocols and Protocolization in Improving Outcome From Severe Traumatic Brain Injury.
Chesnut RM, Temkin N, Videtta W, Lujan S, Petroni G, Pridgeon J, Dikmen S, Chaddock K, Hendrix T, Barber J, Machamer J, Guadagnoli N, Hendrickson P, Alanis V, La Fuente G, Lavadenz A, Merida R, Sandi Lora F, Romero R, Pinillos O, Urbina Z, Figueroa J, Ochoa M, Davila R, Mora J, Bustamante L, Perez C, Leiva J, Carricondo C, Mazzola AM, Guerra J. Chesnut RM, et al. Neurosurgery. 2023 Dec 5. doi: 10.1227/neu.0000000000002777. Online ahead of print. Neurosurgery. 2023. PMID: 38051042
RESULTS: A total of 501 patients (86% male, mean age 35.4 years) enrolled; 81% had 6 months of follow-up. Adopting CREVICE from no protocol was associated with significantly superior results for overall 6-month extended Glasgow Outcome Score (GOSE) (protocol effect …
RESULTS: A total of 501 patients (86% male, mean age 35.4 years) enrolled; 81% had 6 months of follow-up. Adopting CREVICE from no pr …
313 results